Matches in Wikidata for { <http://www.wikidata.org/entity/Q93704681> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q93704681 description "clinical trial" @default.
- Q93704681 description "ensayo clínico" @default.
- Q93704681 description "ensayu clínicu" @default.
- Q93704681 description "klinisch onderzoek" @default.
- Q93704681 description "клінічне випробування" @default.
- Q93704681 description "临床试验" @default.
- Q93704681 name "Trial Evaluating Efficacy and Safety of Bevacizumab (Avastin®/Zeribev®) in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort" @default.
- Q93704681 name "Trial Evaluating Efficacy and Safety of Bevacizumab (Avastin®/Zeribev®) in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort" @default.
- Q93704681 type Item @default.
- Q93704681 label "Trial Evaluating Efficacy and Safety of Bevacizumab (Avastin®/Zeribev®) in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort" @default.
- Q93704681 label "Trial Evaluating Efficacy and Safety of Bevacizumab (Avastin®/Zeribev®) in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort" @default.
- Q93704681 prefLabel "Trial Evaluating Efficacy and Safety of Bevacizumab (Avastin®/Zeribev®) in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort" @default.
- Q93704681 prefLabel "Trial Evaluating Efficacy and Safety of Bevacizumab (Avastin®/Zeribev®) in Patients With COVID-19 Infection, Nested in the Corimmuno-19 Cohort" @default.
- Q93704681 P1050 Q93704681-140230C0-5D7F-453F-B278-1E1D8995033D @default.
- Q93704681 P1132 Q93704681-A51CB880-E0B9-4AF8-979A-6E31B170B899 @default.
- Q93704681 P1476 Q93704681-EB07C423-B2F2-40FA-9C85-396E359DF317 @default.
- Q93704681 P1813 Q93704681-28F99EB6-9257-4C0D-96E7-23D817C0908F @default.
- Q93704681 P2899 Q93704681-6E7A15FB-3A5F-49CF-AC51-198FA552FD1A @default.
- Q93704681 P3098 Q93704681-49A664E7-7EEB-4DF5-8138-451ED0C60700 @default.
- Q93704681 P31 Q93704681-49D90261-53A3-4966-9A36-49C924C1C40E @default.
- Q93704681 P4844 Q93704681-9F2980B9-A194-476A-8B43-E86B50185FE9 @default.
- Q93704681 P580 Q93704681-5DF46704-BAF0-4ACE-BA42-22EE32218972 @default.
- Q93704681 P582 Q93704681-CA560648-B3EB-47CF-BBD7-3244D637BD97 @default.
- Q93704681 P6099 Q93704681-4670704B-7356-40F8-95AC-7238C205B769 @default.
- Q93704681 P8005 Q93704681-E8371210-BBCF-47B2-95C0-785E0089D15C @default.
- Q93704681 P8363 Q93704681-932E75A5-85EF-46D1-ACA4-F4F80642C90A @default.
- Q93704681 P859 Q93704681-22017735-A85D-4160-9DA7-81F2250F622F @default.
- Q93704681 P1050 Q12192 @default.
- Q93704681 P1132 "+130" @default.
- Q93704681 P1476 "Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients CORIMUNO-19- BEVA Trial" @default.
- Q93704681 P1813 "CORIMMUNO-BEVA" @default.
- Q93704681 P2899 "+18" @default.
- Q93704681 P3098 "NCT04344782" @default.
- Q93704681 P31 Q30612 @default.
- Q93704681 P4844 Q413299 @default.
- Q93704681 P580 "2020-04-15T00:00:00Z" @default.
- Q93704681 P582 "2020-09-30T00:00:00Z" @default.
- Q93704681 P6099 Q42824440 @default.
- Q93704681 P8005 Q76649614 @default.
- Q93704681 P8363 Q78089383 @default.
- Q93704681 P859 Q2867205 @default.